WallStreetZenWallStreetZen

NASDAQ: RMTI
Rockwell Medical Inc Stock Forecast, Predictions & Price Target

Analyst price target for RMTI

Based on 1 analyst offering 12 month price targets for Rockwell Medical Inc.
Min Forecast
$9.00+520.69%
Avg Forecast
$9.00+520.69%
Max Forecast
$9.00+520.69%

Should I buy or sell RMTI stock?

Based on 1 analyst offering ratings for Rockwell Medical Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RMTI stock forecasts and price targets.

RMTI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-25

1 of 1

Forecast return on equity

Is RMTI forecast to generate an efficient return?

Forecast return on assets

Is RMTI forecast to generate an efficient return on assets?

RMTI revenue forecast

What is RMTI's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$88.1M+5.34%
Avg 2 year Forecast
$104.0M+24.43%
RMTI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RMTI revenue growth forecast

How is RMTI forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
5.34%
Industry
13.47%
Market
13.2%
RMTI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RMTI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RMTI vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
RMTI$1.45$9.00+520.69%Buy
BGXX$0.21N/AN/A
IXHL$2.38N/AN/A
CYTH$1.16N/AN/A
SCYX$1.44N/AN/A

Rockwell Medical Stock Forecast FAQ

Is Rockwell Medical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: RMTI) stock is to Buy RMTI stock.

Out of 1 analyst, 0 (0%) are recommending RMTI as a Strong Buy, 1 (100%) are recommending RMTI as a Buy, 0 (0%) are recommending RMTI as a Hold, 0 (0%) are recommending RMTI as a Sell, and 0 (0%) are recommending RMTI as a Strong Sell.

If you're new to stock investing, here's how to buy Rockwell Medical stock.

What is RMTI's revenue growth forecast for 2024-2025?

(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of 5.34% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 13.47%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.2%.

Rockwell Medical's revenue in 2024 is $83,612,000.On average, 1 Wall Street analysts forecast RMTI's revenue for 2024 to be $2,583,793,065, with the lowest RMTI revenue forecast at $2,583,793,065, and the highest RMTI revenue forecast at $2,583,793,065.

In 2025, RMTI is forecast to generate $3,051,973,553 in revenue, with the lowest revenue forecast at $3,051,973,553 and the highest revenue forecast at $3,051,973,553.

What is RMTI's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: RMTI) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 13.08%.

What is RMTI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year RMTI price target, the average RMTI price target is $9.00, with the highest RMTI stock price forecast at $9.00 and the lowest RMTI stock price forecast at $9.00.

The Wall Street analyst predicted that Rockwell Medical's share price could reach $9.00 by Mar 25, 2025. The average Rockwell Medical stock price prediction forecasts a potential upside of 520.69% from the current RMTI share price of $1.45.

What is RMTI's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: RMTI) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.